Effect of androgen deprivation therapy on serum levels of sclerostin, Dickkopf-1, and osteoprotegerin: a cross-sectional and longitudinal analysis

Androgen deprivation therapy (ADT) for men with prostate cancer (PCa) results in accelerated bone loss and increased risk of bone fracture. The aim of the present study was to evaluate serum bone markers—sclerostin, Dickkopf-1 (DKK-1) and osteoprotegerin (OPG), in a cohort of 88 PCa patients without...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Sci Rep
Prif Awduron: Wang, Alice, Karunasinghe, Nishi, Plank, Lindsay D., Zhu, Shuotun, Osborne, Sue, Brown, Charis, Bishop, Karen, Schwass, Tiffany, Tijono, Sofian, Holmes, Michael, Masters, Jonathan, Huang, Roger, Keven, Christine, Ferguson, Lynnette R., Lawrenson, Ross
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Nature Publishing Group UK 2021
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8295319/
https://ncbi.nlm.nih.gov/pubmed/34290287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-94090-y
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg